In-silico analysis of non-synonymous single nucleotide polymorphisms in human β-defensin type 1 gene reveals their impact on protein-ligand binding sites-Reference-Cited by-同舟云学术

In-silico analysis of non-synonymous single nucleotide polymorphisms in human β-defensin type 1 gene reveals their impact on protein-ligand binding sites

Published:2022-06 Issue: Volume:98 Page:107669
ISSN:1476-9271
Container-title:Computational Biology and Chemistry
language:en
Short-container-title:Computational Biology and Chemistry

Author:

Fareed Muhammad Mazhar,Ullah Sana,Aziz Shan,Johnsen Todd Axel,Shityakov Sergey

Publisher

Elsevier BV

Subject

Computational Mathematics,Organic Chemistry,Biochemistry,Structural Biology

Reference52 articles.

1. Computational analysis of single nucleotide polymorphism (SNPs) in HumanSLC5A1 Gene;Abbas;Int. J. Biomed. Sci. Eng.,2019

2. Predicting functional effect of human missense mutations using PolyPhen‐2;Adzhubei;Curr. Protoc. Hum. Genet.,2013

3. The use of SNPs in pharmacogenomics studies;Alwi;Malays. J. Med. Sci.: MJMS,2005

4. Increased expression of beta-defensin 1 (DEFB1) in chronic obstructive pulmonary disease;Andresen;PLoS One,2011

5. Gene-gene interaction and functional impact of polymorphisms on innate immune genes in controlling plasmodium falciparum blood infection level;Basu;PLoS One,2012

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Illuminating the Role of Curcumin for Breast Cancer Treatment with a New Leu/Val Mutation: An in Silico Study;2024

2. Blood Biomarkers in Takotsubo Syndrome Point to an Emerging Role for Inflammaging in Endothelial Pathophysiology;Biomolecules;2023-06-15

3. Blood biomarkers in Takotsubo syndrome point to an emerging role for inflammaging in disease pathophysiology;2023-04-07

4. HBD-2 variants and SARS-CoV-2: New insights into inter-individual susceptibility;Frontiers in Immunology;2022-12-09

5. In silico investigation of nonsynonymous single nucleotide polymorphisms in BCL2 apoptosis regulator gene to design novel protein‐based drugs against cancer;Journal of Cellular Biochemistry;2022-09-22